Search research articles
Contact Us
Filters
Showing results (141-150 of 163) with videos related to
Page
of 17
Sort By:
Life Science Alliance
|
December 12, 2019
Expression of AXL receptor tyrosine kinase relates to monocyte dysfunction and severity of cirrhosis
Robert Brenig, Oltin T Pop, Evangelos Triantafyllou, et al.
Vaccines
|
July 30, 2025
XBB.1.5 COVID-19 mRNA Vaccines Induce Inadequate Mucosal Immunity in Patients with Inflammatory Bowel Disease
Simon Woelfel, Joel Dütschler, Daniel Junker, et al.
Plos One
|
September 6, 2007
rs1004819 is the main disease-associated IL23R variant in German Crohn's disease patients: combined analysis of IL23R, CARD15, and OCTN1/2 variants
Jürgen Glas, Julia Seiderer, Martin Wetzke, et al.
The American Journal of Gastroenterology
|
March 6, 2009
rs224136 on chromosome 10q21.1 and variants in PHOX2B, NCF4, and FAM92B are not major genetic risk factors for susceptibility to Crohn's disease in the German population
Jürgen Glas, Julia Seiderer, Giulia Pasciuto, et al.
The American Journal of Gastroenterology
|
December 29, 2007
The ATG16L1 gene variants rs2241879 and rs2241880 (T300A) are strongly associated with susceptibility to Crohn's disease in the German population
Jürgen Glas, Astrid Konrad, Silke Schmechel, et al.
Nature
|
April 11, 2014
Protective mucosal immunity mediated by epithelial CD1d and IL-10
Torsten Olszak, Joana F Neves, C Marie Dowds, et al.
Aging Cell
|
March 24, 2016
Immunochip analysis identifies association of the RAD50/IL13 region with human longevity
Friederike Flachsbart, David Ellinghaus, Liljana Gentschew, et al.
Alimentary Pharmacology & Therapeutics
|
October 29, 2024
XBB.1.5-Adapted COVID-19 mRNA Vaccines but Not Infections With Previous Omicron Variants Boost Neutralisation Against the SARS-CoV-2 JN.1 Variant in Patients With Inflammatory Bowel Disease
Simon Woelfel, Joel Dütschler, Daniel Junker, et al.
Inflammatory Intestinal Diseases
|
August 15, 2024
Cohort Profile Update: The Swiss Eosinophilic Esophagitis Cohort Study (SEECS)
Jeanine Wakim El-Khoury, Ekaterina Safroneeva, Catherine Saner, et al.
Vaccines
|
July 27, 2024
Systemic and Mucosal Immunogenicity of Monovalent XBB.1.5-Adapted COVID-19 mRNA Vaccines in Patients with Inflammatory Bowel Disease
Simon Woelfel, Joel Dütschler, Daniel Junker, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 163) with videos related to
Sort By:
Page
of 17
Life Science Alliance
|
December 12, 2019
Expression of AXL receptor tyrosine kinase relates to monocyte dysfunction and severity of cirrhosis
Robert Brenig, Oltin T Pop, Evangelos Triantafyllou, et al.
Vaccines
|
July 30, 2025
XBB.1.5 COVID-19 mRNA Vaccines Induce Inadequate Mucosal Immunity in Patients with Inflammatory Bowel Disease
Simon Woelfel, Joel Dütschler, Daniel Junker, et al.
Plos One
|
September 6, 2007
rs1004819 is the main disease-associated IL23R variant in German Crohn's disease patients: combined analysis of IL23R, CARD15, and OCTN1/2 variants
Jürgen Glas, Julia Seiderer, Martin Wetzke, et al.
The American Journal of Gastroenterology
|
March 6, 2009
rs224136 on chromosome 10q21.1 and variants in PHOX2B, NCF4, and FAM92B are not major genetic risk factors for susceptibility to Crohn's disease in the German population
Jürgen Glas, Julia Seiderer, Giulia Pasciuto, et al.
The American Journal of Gastroenterology
|
December 29, 2007
The ATG16L1 gene variants rs2241879 and rs2241880 (T300A) are strongly associated with susceptibility to Crohn's disease in the German population
Jürgen Glas, Astrid Konrad, Silke Schmechel, et al.
Nature
|
April 11, 2014
Protective mucosal immunity mediated by epithelial CD1d and IL-10
Torsten Olszak, Joana F Neves, C Marie Dowds, et al.
Aging Cell
|
March 24, 2016
Immunochip analysis identifies association of the RAD50/IL13 region with human longevity
Friederike Flachsbart, David Ellinghaus, Liljana Gentschew, et al.
Alimentary Pharmacology & Therapeutics
|
October 29, 2024
XBB.1.5-Adapted COVID-19 mRNA Vaccines but Not Infections With Previous Omicron Variants Boost Neutralisation Against the SARS-CoV-2 JN.1 Variant in Patients With Inflammatory Bowel Disease
Simon Woelfel, Joel Dütschler, Daniel Junker, et al.
Inflammatory Intestinal Diseases
|
August 15, 2024
Cohort Profile Update: The Swiss Eosinophilic Esophagitis Cohort Study (SEECS)
Jeanine Wakim El-Khoury, Ekaterina Safroneeva, Catherine Saner, et al.
Vaccines
|
July 27, 2024
Systemic and Mucosal Immunogenicity of Monovalent XBB.1.5-Adapted COVID-19 mRNA Vaccines in Patients with Inflammatory Bowel Disease
Simon Woelfel, Joel Dütschler, Daniel Junker, et al.
Page
of 17